Single-Domain Antibody Platforms Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Platform Type (Multi Specific Single Domain Antibody, Bispecific Single Domain Antibody, Multivalent Single Domain Antibody, Mono Specific Single Domain Antibody); Animal Source (Camelids, Shark); Application (Diagnostic Development, Therapeutic Development, Research and Developmental Activities); End User (Pharmaceutical land Biotechnology Companies, Academic and Research Institutes, Others)

Report Code: TIPRE00019993 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
Covid
MARKET INTRODUCTION

Single-domain antibodies are an alternative for monoclonal owing to smaller size, low production costs, and potent inhibitors against immune and viral diseases. These are highly successful against infections, including hepatitis C virus, influenza viruses, HIV-1, and enteric viruses.

MARKET DYNAMICS

The single-domain antibody platforms market is driving due to advancements in pharmaceutical therapies such as personalized therapies and increasing medical research to discover novel innovative drugs. However, dearth of skilled professionals is expected to hamper the growth of the global single-domain antibody platforms market. Moreover, implementation of single-domain antibodies for drug discovery is anticipated to drive demand the growth of the market.

MARKET SCOPE

The "Single-Domain Antibody Platforms Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of single-domain antibody platforms market with detailed market segmentation by platform type, animal source, application, end user. The single-domain antibody platforms market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in single-domain antibody platforms market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The single-domain antibody platforms market is segmented based on platform type, animal source, application, end user. Based on platform type, the market is segmented into multi specific single domain antibody, bispecific single domain antibody, multivalent single domain antibody, mono specific single domain antibody. Based on animal source, the market is segmented into camelids, shark. Based on application, the market is segmented into, diagnostic development, therapeutic development, and research & developmental activities. Based on end user, the market is segmented into pharmaceutical & biotechnology companies, academic & research institutes, others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the single-domain antibody platforms market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The single-domain antibody platforms market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting single-domain antibody platforms market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely, North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social, and technological factors effecting the single-domain antibody platforms market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the single-domain antibody platforms market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from single-domain antibody platforms market are anticipated to have lucrative growth opportunities in the future with the rising demand for single-domain antibody platforms market in the global market. Below mentioned is the list of few companies engaged in the single-domain antibody platforms market.

The report also includes the profiles of key players in single-domain antibody platforms market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Creative BioLabs A
  •   Synbio Technologies
  •   ProSci Incorporated
  •   BioCat GmbH
  •   Antibody Design Labs
  •   GenScript
  •   Oak BioSciences, Inc.
  •   Rockland Immunochemicals, Inc
  •   Hybrigenics Services
  •   NeoClone Biotechnology International LLC

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Single-Domain Antibody Platforms Market - By Platform Type
1.3.2 Single-Domain Antibody Platforms Market - By Animal Source
1.3.3 Single-Domain Antibody Platforms Market - By Application
1.3.4 Single-Domain Antibody Platforms Market - By End User
1.3.5 Single-Domain Antibody Platforms Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. SINGLE-DOMAIN ANTIBODY PLATFORMS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. SINGLE-DOMAIN ANTIBODY PLATFORMS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. SINGLE-DOMAIN ANTIBODY PLATFORMS MARKET - GLOBAL MARKET ANALYSIS
6.1. SINGLE-DOMAIN ANTIBODY PLATFORMS - GLOBAL MARKET OVERVIEW
6.2. SINGLE-DOMAIN ANTIBODY PLATFORMS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. SINGLE-DOMAIN ANTIBODY PLATFORMS MARKET - REVENUE AND FORECASTS TO 2028 - PLATFORM TYPE
7.1. OVERVIEW
7.2. PLATFORM TYPE MARKET FORECASTS AND ANALYSIS
7.3. MULTI SPECIFIC SINGLE DOMAIN ANTIBODY
7.3.1. Overview
7.3.2. Multi Specific Single Domain Antibody Market Forecast and Analysis
7.4. BISPECIFIC SINGLE DOMAIN ANTIBODY
7.4.1. Overview
7.4.2. Bispecific Single Domain Antibody Market Forecast and Analysis
7.5. MULTIVALENT SINGLE DOMAIN ANTIBODY
7.5.1. Overview
7.5.2. Multivalent Single Domain Antibody Market Forecast and Analysis
7.6. MONO SPECIFIC SINGLE DOMAIN ANTIBODY
7.6.1. Overview
7.6.2. Mono Specific Single Domain Antibody Market Forecast and Analysis
8. SINGLE-DOMAIN ANTIBODY PLATFORMS MARKET - REVENUE AND FORECASTS TO 2028 - ANIMAL SOURCE
8.1. OVERVIEW
8.2. ANIMAL SOURCE MARKET FORECASTS AND ANALYSIS
8.3. CAMELIDS
8.3.1. Overview
8.3.2. Camelids Market Forecast and Analysis
8.4. SHARK
8.4.1. Overview
8.4.2. Shark Market Forecast and Analysis
9. SINGLE-DOMAIN ANTIBODY PLATFORMS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. DIAGNOSTIC DEVELOPMENT
9.3.1. Overview
9.3.2. Diagnostic Development Market Forecast and Analysis
9.4. THERAPEUTIC DEVELOPMENT
9.4.1. Overview
9.4.2. Therapeutic Development Market Forecast and Analysis
9.5. RESEARCH AND DEVELOPMENTAL ACTIVITIES
9.5.1. Overview
9.5.2. Research and Developmental Activities Market Forecast and Analysis
10. SINGLE-DOMAIN ANTIBODY PLATFORMS MARKET - REVENUE AND FORECASTS TO 2028 - END USER
10.1. OVERVIEW
10.2. END USER MARKET FORECASTS AND ANALYSIS
10.3. PHARMACEUTICA LAND BIOTECHNOLOGY COMPANIES
10.3.1. Overview
10.3.2. Pharmaceutica land Biotechnology Companies Market Forecast and Analysis
10.4. ACADEMIC AND RESEARCH INSTITUTES
10.4.1. Overview
10.4.2. Academic and Research Institutes Market Forecast and Analysis
10.5. OTHERS
10.5.1. Overview
10.5.2. Others Market Forecast and Analysis
11. SINGLE-DOMAIN ANTIBODY PLATFORMS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Single-Domain Antibody Platforms Market Overview
11.1.2 North America Single-Domain Antibody Platforms Market Forecasts and Analysis
11.1.3 North America Single-Domain Antibody Platforms Market Forecasts and Analysis - By Platform Type
11.1.4 North America Single-Domain Antibody Platforms Market Forecasts and Analysis - By Animal Source
11.1.5 North America Single-Domain Antibody Platforms Market Forecasts and Analysis - By Application
11.1.6 North America Single-Domain Antibody Platforms Market Forecasts and Analysis - By End User
11.1.7 North America Single-Domain Antibody Platforms Market Forecasts and Analysis - By Countries
11.1.7.1 United States Single-Domain Antibody Platforms Market
11.1.7.1.1 United States Single-Domain Antibody Platforms Market by Platform Type
11.1.7.1.2 United States Single-Domain Antibody Platforms Market by Animal Source
11.1.7.1.3 United States Single-Domain Antibody Platforms Market by Application
11.1.7.1.4 United States Single-Domain Antibody Platforms Market by End User
11.1.7.2 Canada Single-Domain Antibody Platforms Market
11.1.7.2.1 Canada Single-Domain Antibody Platforms Market by Platform Type
11.1.7.2.2 Canada Single-Domain Antibody Platforms Market by Animal Source
11.1.7.2.3 Canada Single-Domain Antibody Platforms Market by Application
11.1.7.2.4 Canada Single-Domain Antibody Platforms Market by End User
11.1.7.3 Mexico Single-Domain Antibody Platforms Market
11.1.7.3.1 Mexico Single-Domain Antibody Platforms Market by Platform Type
11.1.7.3.2 Mexico Single-Domain Antibody Platforms Market by Animal Source
11.1.7.3.3 Mexico Single-Domain Antibody Platforms Market by Application
11.1.7.3.4 Mexico Single-Domain Antibody Platforms Market by End User
11.2. EUROPE
11.2.1 Europe Single-Domain Antibody Platforms Market Overview
11.2.2 Europe Single-Domain Antibody Platforms Market Forecasts and Analysis
11.2.3 Europe Single-Domain Antibody Platforms Market Forecasts and Analysis - By Platform Type
11.2.4 Europe Single-Domain Antibody Platforms Market Forecasts and Analysis - By Animal Source
11.2.5 Europe Single-Domain Antibody Platforms Market Forecasts and Analysis - By Application
11.2.6 Europe Single-Domain Antibody Platforms Market Forecasts and Analysis - By End User
11.2.7 Europe Single-Domain Antibody Platforms Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Single-Domain Antibody Platforms Market
11.2.7.1.1 Germany Single-Domain Antibody Platforms Market by Platform Type
11.2.7.1.2 Germany Single-Domain Antibody Platforms Market by Animal Source
11.2.7.1.3 Germany Single-Domain Antibody Platforms Market by Application
11.2.7.1.4 Germany Single-Domain Antibody Platforms Market by End User
11.2.7.2 France Single-Domain Antibody Platforms Market
11.2.7.2.1 France Single-Domain Antibody Platforms Market by Platform Type
11.2.7.2.2 France Single-Domain Antibody Platforms Market by Animal Source
11.2.7.2.3 France Single-Domain Antibody Platforms Market by Application
11.2.7.2.4 France Single-Domain Antibody Platforms Market by End User
11.2.7.3 Italy Single-Domain Antibody Platforms Market
11.2.7.3.1 Italy Single-Domain Antibody Platforms Market by Platform Type
11.2.7.3.2 Italy Single-Domain Antibody Platforms Market by Animal Source
11.2.7.3.3 Italy Single-Domain Antibody Platforms Market by Application
11.2.7.3.4 Italy Single-Domain Antibody Platforms Market by End User
11.2.7.4 Spain Single-Domain Antibody Platforms Market
11.2.7.4.1 Spain Single-Domain Antibody Platforms Market by Platform Type
11.2.7.4.2 Spain Single-Domain Antibody Platforms Market by Animal Source
11.2.7.4.3 Spain Single-Domain Antibody Platforms Market by Application
11.2.7.4.4 Spain Single-Domain Antibody Platforms Market by End User
11.2.7.5 United Kingdom Single-Domain Antibody Platforms Market
11.2.7.5.1 United Kingdom Single-Domain Antibody Platforms Market by Platform Type
11.2.7.5.2 United Kingdom Single-Domain Antibody Platforms Market by Animal Source
11.2.7.5.3 United Kingdom Single-Domain Antibody Platforms Market by Application
11.2.7.5.4 United Kingdom Single-Domain Antibody Platforms Market by End User
11.2.7.6 Rest of Europe Single-Domain Antibody Platforms Market
11.2.7.6.1 Rest of Europe Single-Domain Antibody Platforms Market by Platform Type
11.2.7.6.2 Rest of Europe Single-Domain Antibody Platforms Market by Animal Source
11.2.7.6.3 Rest of Europe Single-Domain Antibody Platforms Market by Application
11.2.7.6.4 Rest of Europe Single-Domain Antibody Platforms Market by End User
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Single-Domain Antibody Platforms Market Overview
11.3.2 Asia-Pacific Single-Domain Antibody Platforms Market Forecasts and Analysis
11.3.3 Asia-Pacific Single-Domain Antibody Platforms Market Forecasts and Analysis - By Platform Type
11.3.4 Asia-Pacific Single-Domain Antibody Platforms Market Forecasts and Analysis - By Animal Source
11.3.5 Asia-Pacific Single-Domain Antibody Platforms Market Forecasts and Analysis - By Application
11.3.6 Asia-Pacific Single-Domain Antibody Platforms Market Forecasts and Analysis - By End User
11.3.7 Asia-Pacific Single-Domain Antibody Platforms Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Single-Domain Antibody Platforms Market
11.3.7.1.1 Australia Single-Domain Antibody Platforms Market by Platform Type
11.3.7.1.2 Australia Single-Domain Antibody Platforms Market by Animal Source
11.3.7.1.3 Australia Single-Domain Antibody Platforms Market by Application
11.3.7.1.4 Australia Single-Domain Antibody Platforms Market by End User
11.3.7.2 China Single-Domain Antibody Platforms Market
11.3.7.2.1 China Single-Domain Antibody Platforms Market by Platform Type
11.3.7.2.2 China Single-Domain Antibody Platforms Market by Animal Source
11.3.7.2.3 China Single-Domain Antibody Platforms Market by Application
11.3.7.2.4 China Single-Domain Antibody Platforms Market by End User
11.3.7.3 India Single-Domain Antibody Platforms Market
11.3.7.3.1 India Single-Domain Antibody Platforms Market by Platform Type
11.3.7.3.2 India Single-Domain Antibody Platforms Market by Animal Source
11.3.7.3.3 India Single-Domain Antibody Platforms Market by Application
11.3.7.3.4 India Single-Domain Antibody Platforms Market by End User
11.3.7.4 Japan Single-Domain Antibody Platforms Market
11.3.7.4.1 Japan Single-Domain Antibody Platforms Market by Platform Type
11.3.7.4.2 Japan Single-Domain Antibody Platforms Market by Animal Source
11.3.7.4.3 Japan Single-Domain Antibody Platforms Market by Application
11.3.7.4.4 Japan Single-Domain Antibody Platforms Market by End User
11.3.7.5 South Korea Single-Domain Antibody Platforms Market
11.3.7.5.1 South Korea Single-Domain Antibody Platforms Market by Platform Type
11.3.7.5.2 South Korea Single-Domain Antibody Platforms Market by Animal Source
11.3.7.5.3 South Korea Single-Domain Antibody Platforms Market by Application
11.3.7.5.4 South Korea Single-Domain Antibody Platforms Market by End User
11.3.7.6 Rest of Asia-Pacific Single-Domain Antibody Platforms Market
11.3.7.6.1 Rest of Asia-Pacific Single-Domain Antibody Platforms Market by Platform Type
11.3.7.6.2 Rest of Asia-Pacific Single-Domain Antibody Platforms Market by Animal Source
11.3.7.6.3 Rest of Asia-Pacific Single-Domain Antibody Platforms Market by Application
11.3.7.6.4 Rest of Asia-Pacific Single-Domain Antibody Platforms Market by End User
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Single-Domain Antibody Platforms Market Overview
11.4.2 Middle East and Africa Single-Domain Antibody Platforms Market Forecasts and Analysis
11.4.3 Middle East and Africa Single-Domain Antibody Platforms Market Forecasts and Analysis - By Platform Type
11.4.4 Middle East and Africa Single-Domain Antibody Platforms Market Forecasts and Analysis - By Animal Source
11.4.5 Middle East and Africa Single-Domain Antibody Platforms Market Forecasts and Analysis - By Application
11.4.6 Middle East and Africa Single-Domain Antibody Platforms Market Forecasts and Analysis - By End User
11.4.7 Middle East and Africa Single-Domain Antibody Platforms Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Single-Domain Antibody Platforms Market
11.4.7.1.1 South Africa Single-Domain Antibody Platforms Market by Platform Type
11.4.7.1.2 South Africa Single-Domain Antibody Platforms Market by Animal Source
11.4.7.1.3 South Africa Single-Domain Antibody Platforms Market by Application
11.4.7.1.4 South Africa Single-Domain Antibody Platforms Market by End User
11.4.7.2 Saudi Arabia Single-Domain Antibody Platforms Market
11.4.7.2.1 Saudi Arabia Single-Domain Antibody Platforms Market by Platform Type
11.4.7.2.2 Saudi Arabia Single-Domain Antibody Platforms Market by Animal Source
11.4.7.2.3 Saudi Arabia Single-Domain Antibody Platforms Market by Application
11.4.7.2.4 Saudi Arabia Single-Domain Antibody Platforms Market by End User
11.4.7.3 U.A.E Single-Domain Antibody Platforms Market
11.4.7.3.1 U.A.E Single-Domain Antibody Platforms Market by Platform Type
11.4.7.3.2 U.A.E Single-Domain Antibody Platforms Market by Animal Source
11.4.7.3.3 U.A.E Single-Domain Antibody Platforms Market by Application
11.4.7.3.4 U.A.E Single-Domain Antibody Platforms Market by End User
11.4.7.4 Rest of Middle East and Africa Single-Domain Antibody Platforms Market
11.4.7.4.1 Rest of Middle East and Africa Single-Domain Antibody Platforms Market by Platform Type
11.4.7.4.2 Rest of Middle East and Africa Single-Domain Antibody Platforms Market by Animal Source
11.4.7.4.3 Rest of Middle East and Africa Single-Domain Antibody Platforms Market by Application
11.4.7.4.4 Rest of Middle East and Africa Single-Domain Antibody Platforms Market by End User
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Single-Domain Antibody Platforms Market Overview
11.5.2 South and Central America Single-Domain Antibody Platforms Market Forecasts and Analysis
11.5.3 South and Central America Single-Domain Antibody Platforms Market Forecasts and Analysis - By Platform Type
11.5.4 South and Central America Single-Domain Antibody Platforms Market Forecasts and Analysis - By Animal Source
11.5.5 South and Central America Single-Domain Antibody Platforms Market Forecasts and Analysis - By Application
11.5.6 South and Central America Single-Domain Antibody Platforms Market Forecasts and Analysis - By End User
11.5.7 South and Central America Single-Domain Antibody Platforms Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Single-Domain Antibody Platforms Market
11.5.7.1.1 Brazil Single-Domain Antibody Platforms Market by Platform Type
11.5.7.1.2 Brazil Single-Domain Antibody Platforms Market by Animal Source
11.5.7.1.3 Brazil Single-Domain Antibody Platforms Market by Application
11.5.7.1.4 Brazil Single-Domain Antibody Platforms Market by End User
11.5.7.2 Argentina Single-Domain Antibody Platforms Market
11.5.7.2.1 Argentina Single-Domain Antibody Platforms Market by Platform Type
11.5.7.2.2 Argentina Single-Domain Antibody Platforms Market by Animal Source
11.5.7.2.3 Argentina Single-Domain Antibody Platforms Market by Application
11.5.7.2.4 Argentina Single-Domain Antibody Platforms Market by End User
11.5.7.3 Rest of South and Central America Single-Domain Antibody Platforms Market
11.5.7.3.1 Rest of South and Central America Single-Domain Antibody Platforms Market by Platform Type
11.5.7.3.2 Rest of South and Central America Single-Domain Antibody Platforms Market by Animal Source
11.5.7.3.3 Rest of South and Central America Single-Domain Antibody Platforms Market by Application
11.5.7.3.4 Rest of South and Central America Single-Domain Antibody Platforms Market by End User
12. IMPACT OF COVID-19 PANDEMIC ON GLOBAL SINGLE-DOMAIN ANTIBODY PLATFORMS MARKET
12.1 North America
12.2 Europe
12.3 Asia-Pacific
12.4 Middle East and Africa
12.5 South and Central America
13. INDUSTRY LANDSCAPE
13.1. MERGERS AND ACQUISITIONS
13.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
13.3. NEW PRODUCT LAUNCHES
13.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
14. SINGLE-DOMAIN ANTIBODY PLATFORMS MARKET, KEY COMPANY PROFILES
14.1. CREATIVE BIOLABS A
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Products and Services
14.1.4. Financial Overview
14.1.5. SWOT Analysis
14.1.6. Key Developments
14.2. SYNBIO TECHNOLOGIES
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Products and Services
14.2.4. Financial Overview
14.2.5. SWOT Analysis
14.2.6. Key Developments
14.3. PROSCI INCORPORATED
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Products and Services
14.3.4. Financial Overview
14.3.5. SWOT Analysis
14.3.6. Key Developments
14.4. BIOCAT GMBH
14.4.1. Key Facts
14.4.2. Business Description
14.4.3. Products and Services
14.4.4. Financial Overview
14.4.5. SWOT Analysis
14.4.6. Key Developments
14.5. ANTIBODY DESIGN LABS
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Products and Services
14.5.4. Financial Overview
14.5.5. SWOT Analysis
14.5.6. Key Developments
14.6. GENSCRIPT
14.6.1. Key Facts
14.6.2. Business Description
14.6.3. Products and Services
14.6.4. Financial Overview
14.6.5. SWOT Analysis
14.6.6. Key Developments
14.7. OAK BIOSCIENCES, INC.
14.7.1. Key Facts
14.7.2. Business Description
14.7.3. Products and Services
14.7.4. Financial Overview
14.7.5. SWOT Analysis
14.7.6. Key Developments
14.8. ROCKLAND IMMUNOCHEMICALS, INC
14.8.1. Key Facts
14.8.2. Business Description
14.8.3. Products and Services
14.8.4. Financial Overview
14.8.5. SWOT Analysis
14.8.6. Key Developments
14.9. HYBRIGENICS SERVICES
14.9.1. Key Facts
14.9.2. Business Description
14.9.3. Products and Services
14.9.4. Financial Overview
14.9.5. SWOT Analysis
14.9.6. Key Developments
14.10. NEOCLONE BIOTECHNOLOGY INTERNATIONAL LLC
14.10.1. Key Facts
14.10.2. Business Description
14.10.3. Products and Services
14.10.4. Financial Overview
14.10.5. SWOT Analysis
14.10.6. Key Developments
15. APPENDIX
15.1. ABOUT THE INSIGHT PARTNERS
15.2. GLOSSARY OF TERMS
The List of Companies

1. Creative BioLabs A
2. Synbio Technologies
3. ProSci Incorporated
4. BioCat GmbH
5. Antibody Design Labs
6. GenScript
7. Oak BioSciences, Inc.
8. Rockland Immunochemicals, Inc
9. Hybrigenics Services
10. NeoClone Biotechnology International LLC
TIPRE00019993
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking